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 In community, population older than fifty years of age, about 50% 
develop thyroid nodules. Among them 5% of these nodules are malignant, But it 
does not eliminate the need to screen benign nodules and differentiate it from 
malignant nodules. 
 
Ultrasonography of neck in general population detects 15 to 90%,having  
Thyroid nodules. Thyroid scan-B mode shows characters like dimension, 
contour, echogenicity, presence and type of peripheral halo. It also demonstrates 
the number of nodules. But, usual B mode USG cannot differentiate benign 
nodules from malignant nodules. 
 
 In evaluation of thyroid swelling, FNAC plays a vital role. But, FNAC is 
not always diagnostic (eg. suspicious findings, insufficient materials, false 
positive or non diagnostic results).This can occur up to about 28% of samples. 
Moreover FNAC cannot differentiate follicular adenoma from follicular 
carcinoma. These limitations can be bridged by using high frequency Doppler 
scan, that can detect blood flow in thyroid gland and other superficial tissues. It 
is based on the simple principle that increase in vascularity is associated with 
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increased proliferation of cells. Doppler USG provides information about 
nodule vascularisation and is useful in identification of atrisk nodules for 
malignancy by analyzing various parameters like resistance index, pulsatility 
index and filling patterns. 
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AIM 
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1) To Evaluate that Doppler USG is useful in diagnosing thyroid nodules 
at risk for malignancy, more importantly in differentiating benign 
follicular neoplasm from malignant follicular neoplasm 
 
2) It aids in management of patients with solitary nodule of thyroid with 
high risk for malignancy that they may directly undergo total 
thyroidectomy rather than going for hemithyroidectomy and later for 
second stage completion thyroidectomy, 
 
This is a prospective study in patients with thyroid nodules. Patients were 
recruited after obtaining informed consent, details of clinical diagnosis, 
preoperative investigations, FNAC, USG neck and USG Doppler, postoperative 
histopathology, followup period were recorded. Data analysed and results 
interpreted. Ethical approval for the study was obtained from ethical committee, 
THANJAVUR MEDICAL COLLEGE AND HOSPITAL, THANJAVUR. 
 
 
6 
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
 
 
 
7 
 
DEVELOPMENT 
 The thyroid gland develops from a median down growth of a column of 
cells from the pharyngeal floor between the first and second  pharyngeal 
pouches (Subsequently marked by the  foramen caecum of the tongue). 
The canalised column becomes the thyroglossal duct which is displaced forward 
by the developing hyoid bone and then below the hyoid, lies slightly to one side, 
more commonly to the left. The duct bifurcates to from the thyroid lobes and a 
portion of the duct forms the pyramidal lobe. 
ANATOMY 
 It is located in the anterior triangle of the neck. It weighs about 20 grams. 
PARTS 
 Right and left lateral lobes located in a space (thyroid fossa) between 
trachea and oesophagus medically and carotid sheath laterally. Each lobe 
is 5x3 x1.5 cm in size, extends from the middle of the thyroid cartilage to 
6th tracheal ring. 
 Isthmus is the connecting part between two lateral lobes in midline 
extending from 2nd to 4th tracheal ring. 
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 Pyramidal lobe is upward extension as fibrous strands or muscular 
strands from the junction of the isthmus and left lateral lobe. 
 Gland is invested by pretracheal fascia. 
BLOOD SUPPLY 
 Superior thyroid artery is first anterior branch of external carotid 
artery enters the gland near superior pole as a larger anterior 
superficial branch and a smaller posterior branch. 
 Inferior thyroid artery, a branch of thyrocervical trunk of subclavian 
artery passes behind the carotid sheath running medially reaching 
the posterolateral aspect of the gland. 
 Thyroidea ima artery, a branch of aorta or brachiocephalic artery 
enters the isthmus or lower pole of one of the lateral lobes (10%) 
 Tracheal and oesophageal branches serve blood supply to retained 
thyroid gland after thyroidectomy. 
VENOUS DRAINAGE 
 Superior thyroid vein  
 Middle thyroid vein is short and drains into the internal jugular 
vein. It is first to be ligated in thyroidectomy. 
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 Inferior thyroid veins are many in number. 
 Kocher's vein may be present which drains lower or middle 
thyroid. 
LYMPHATIC DRAINAGE 
Primary: 
 Tracheo-oesophageal nodes. 
 Prelaryngeal nodes (Delphian nodes). Formerly purpose of these 
lymph nodes were uncertain hence the name .Delphi is a place in 
Greece where Pythia, snake women after sulphurous fume 
inhalation uttered meaningless jargon purpose of it was unclear. 
 Mediastinal nodes 
Secondary: 
 Deep cervical nodes. 
 Supraclavicular nodes. 
 Occipital nodes. 
 Ascending medial lymph vessels from the upper border of 
isthmus drain to prelaryngeal nodes which are located in the 
cricothyroid membrane. 
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 Ascending lateral vessels from the upper pole of the gland 
along the superior thyroid artery drain into deep cervical 
nodes. 
 Descending medial vessels begins at lower part of the 
isthmus to reach pretracheal lymph nodes. 
 Descending lateral vessels run from the deep surface of the 
thyroid to recurrent laryngeal chain nodes. 
IMPORTANT RELATIONS OF THYROID GLAND 
 Recurrent laryngeal nerve lies in the tracheooesophageal groove, in 
relation to Berry's ligament. 
 Superior laryngeal nerve which gives a branch, external laryngeal 
nerve supplies cricothyroid muscle. It accompanies superior 
thyroid artery. 
 Parathyroid glands  - four in number, two on each side embedded 
in thyroid. 
PHYSIOLOGY 
 Thyroid gland  has two secretory cells: 
              1. Follicular cells - secretes  thyroid hormones (Thyroxine (T4), Tri-  
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                  iodothyronine (T3). 
              2. Parafollicular  cells ('C' Cells) - secretes calcitonin. 
 
IODINE METABOLISM 
  Ninety per cent of body iodide uptake is in the thyroid gland, 
whose uptake into the follicular cells is regulated by TSH and follicular iodide 
content. 
THYROID HORMONE SYNTHESIS 
 Iodothyronins (MIT, DIT) are formed in follicular cells by the coupling 
of inorganic iodide with tyrosine. These are biologically inert molecules. T4 
(Thyroxine) is  formed by coupling of 2 DIT molecules and T3 (Tri-
iodothyronine) is formed by coupling of 1 MIT and 1 DIT molecules. Both are 
bound to thyroglobin which is the primary component of colloid matrix. 
 The hypothalamus-pituitary-thyroid axis regulates thyroid hormone 
production and releases in a classic feedback system. TRH is a regulatory 
hormone from hypothalamus and TSH is a regulatory hormone from anterior 
pituitary. 
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THYROID function tests 
1. T3 (Serum tri-iodothyronine):1.2-3.1 nmol/litre. 80%  of T3 is from 
deiodination of  T4 at periphery in liver, muscle, kidney and pituitary. T3 is 4 
times more potent with half life of 24 hours. 
 2.  T4 (Serum thyroxin):55-150 nmol/litre.  It reflects the output of the 
gland (Edward Calvin Kendall 1915). 
 3. TSH: 0-5 IU/ml of plasma. TSH is secreted from anterior pituitary; its 
secretion is inversely related to circulating thyroid hormones. TSH secretion is 
regulated by TRH from hypothalamus. 
 4. PBI (Protein bound iodide)- 8 mcg/100 ml. 
 5. Free T3 is 0.3% (3-9 nmol/litre). It is the best single test is assessing 
hyperthyroidism. 
 6. Free T4 is 0.03% (8-26  nmol/litre)  
 7. RA I123 scan show either cold nodule, hot nodule, or warm nodule. 
 8. TRH stimulation test for hypothalamic - pituitary axis: Intravenous 
TRH (200 mg) shows rise in serum TSH level in 20 minutes (from basal 1 m 
unit/ml to 10 m unit/ml) and reaches to normal in 2 hours. Patients with 
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pituitary insufficiency developa subnormal response, patient with 
hypothyroidism will show enhanced TSH response; in hypothyroidism there 
will be no response. This test is useful in doubtful hyperthyroidism, 
hypothyroidism, T3 thyrotoxicosis, Ophthalmic Graves’ disease. 
 9. Serum creatinine is increased in hyperthyroidism; decreased in 
hypothyroidism. 
 10. Serum cholesterol is increased in hypothyroidism and decreased in 
hyperthyroidism. 
 11. BMR is increaed in hyperthyroidism. 
 12. Thyroid autoantibodies are also useful to evaluate the function 
(LATS). TSH receptor antibodies (TSH RAb) has got long acting potential  and 
are reasons for all primary thyrotoxicosis. 
 13. Werner's T3 Suppression test: Initial isotope uptake study is done. 40 
mcg of T3  is given to the patient orally 8th hourly for 5 days.  Uptake study is 
repeated. In normal uptake suppression up to 80% is noted. In toxic goitre 
suppression is 10-20%. It is used in patients with antithyroid drugs for primary 
thyrotoxicosis to assess the remission status. 
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 14. Thyroglubulin estimation: Normal value is 0.5-50 mg/L. It is used 
during follow up period especially in follicular  carcinoma of thyroid. But if 
thyroglobulin antibodies are raised in patient, then it is of no use. Thyroglobulin 
is produced only by the thyroid tissue. After total thyroidectomy, its level  
drastically reduces. It is the ideal follow up marker in well differentiated thyroid 
carcinoma after thyroidectomy. Sudden raise in its serum can occur in 
thyroiditis, primary or secondary toxic goitre. 
 
FNAC OF THYROID  
 It is the investigation of choice in most of the thyroid diseases to 
conclude pathological diagnosis. 
 It is useful in papillary/medullary (amyloid)/anaplastic carcinomas, 
lymphomas, colloid nodule, thyroiditis. 
 23G needle is used. Suspicious solitary/multiple nodules/dominant 
nodules should be aspirated. 
 Karolinska hospital (Lowhagen) at Sweden pioneered this method. 
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 Minimum 6 aspirations should be done. An adequate FNAC smear 
should have six aspirations with six groups of cells with each group 
containing 20 cells. USG guided aspiration is better. 
 Diagnostic accuracy of FNAC is 95%; sensitivity 85%; Specificity 
94%. 
 Aspiration is graded as: Thy1-Nondiagnostic;Thy2-
Nonneoplastic;Thy3-Follicular;Thy4-Suspicious of malignancy;  
Thy 5 - malignancy. 
 In a cyst of thyroid FNAC may be less reliable; if cyst recurs after 
3 aspirations, surgery is needed. 
 Malignancy rate in a simple cyst is 5%; in a complex cyst it is 
75%. 
 FNAC is not reliable at present in follicular carcinoma of thyroid 
as capsular and vascular invasions cannot be found. But by newer 
technique it is possible to identify the differences - Benign is 
polyploidy, malignant is aneuploidy;benign are monoclonal, 
malignant are polyclonal; MR spectroscopy and 
thyroimmunoperoxidase estimation are useful to differentiate. 
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 FNNAC is the fine needle nonaspiration cytology - is said to be 
more reliable. 
USG IN THYROID 
 To identify nodules, number, size, vascularity, echogenicity. 
 To do USG guided FNAC. 
 To identify neck lymph nodes 
 To find out solid or cystic nature. 
 Benign lesion is hyperechoic, often cystic with well-defined 
margin; shows peripheral egg shell calcification with sonolucent 
rim (halo) around nodule. 
 Malignant lesion is hypoechoic with poorly defined margin with 
high vascularity, with microcalcification without any halo 
around. 
 
CLASSIFICATION OF GOITRE 
 Goitre is enlargement of thyroid  gland. ('goitre'-latin-gutter- throat) 
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1.Simple nontoxic 
a. Diffuse hyperplastic: 
 - Physiological   
-Puberty. 
 - Pregnancy  
 - Primary iodine deficiency (Endemic; dietary iodine intake less   
           than 100 mg/day). 
 - Secondary iodine deficiency: 
     - Goitrogens of Brassica family, e.g. cabbage, soyabean. Common  
              in hill station. 
 - Excess dietary fluoride. 
 -Drugs: PAS, lithium, phenylbutazone, thiocyanates, potassium  
           perchlorate, antithyroid durgs, radioactive iodine. 
 - Dyshormonogenetic goitre. 
b. Colloid goitre. 
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c. Nodular goitre (Multinodular). 
d. Solitary nontoxic nodule. 
e. Recurrent nontoxic  nodule. 
2.Toxic 
 a. Diffuse (Primary) -Graves disease. 
 b. Multinodular (Secondary) -Plummer's disease. 
 c.Toxic nodule (Solitary) (Tretiary) 
 d. Recurrent toxicosis.  
3.Neoplastic 
 a.Benign - adenomas:follicular,Hurthle cell. 
 b. Malignant: 
  -Carcinomas: Papillary, follicular, medullary, anaplastic. 
  - Lymphomas. 
4.Thyroiditis 
 a. Hashimoto's autoimmune thyroiditis. 
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 b. de-Quervain's autoimmune thyroiditis. 
 c. Riedel's thyroiditis. 
5. Rare causes: Bacterial (suppurative), amyloid. 
DIFFUSE HYPERPLASTIC GOITRE 
 Initial persistent increase in TSH level causes diffuse active lobules. In 
late stages of diffuse hyperplasia, TSH stimulation decreases and many follicles 
become inactive ,get filled with colloid and it is called as colloid goitre. 
 As diffuse hyperplastic goitre is a reversible stage, L-thyroxine is 
beneficial. 
MULTINODULAR GOITRE (MNG) 
• MNG is discordant growth with functionally and structurally 
altered   thyroid follicles presenting as multiple nodules in 
thyroid. 
 
• It may be due to mainly fluctuation in TSH level; other causes 
may be iodine deficiency, goitrogens, 
hereditary,dyshormonogenesis. 
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• Other factors involved are growth stimulating 
immunoglobulins  and growth prone cell clones. 
 
STAGES OF MULTINODULAR GOITRE FORMATION  
• Stage of hyperplasia and hypertrophy 
• Stage of fluctuation in TSH 
• Stage of information of nodules 
Colloid goitre is a goitre to long standing iodine deficiency with 
localised accumulation of significant colloid in the gland. 
CLINICAL FEATURES 
 More common in middle aged females  
 It is a slowly progressive disease with many years of history. 
 Multiple nodules of different sizes are formed in both lobes, also in 
isthmus, which is firm, nodular, nontender, moves with deglutition. 
 Recent increase in size signifies malignant transformation or 
haemorrhage. 
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 Positive Kocher’s test is due to compression over 
trachea(tracheomalacia/scabbard trachea) in a long standing MNG. 
 Nodule when calcified becomes  harder; necrosis softens the 
nodule. 
COMPLICATIONS OF MNG 
 Secondary  thyrotoxicosis (30%) 
 Follicular carcinoma of thyroid (10%) 
 Haemorrhage in a nodule 
 Tracheal obstruction, calcification 
 Cosmetic problem. 
INVESTIGATION 
 T3, T4, TSH, U/S neck, FNAC. FNAC is done from most 
dominant and suspicious nodule. FNAC from more than one 
nodule is better; US guided FNAC is more reliable. High resolution 
US identifies impalpable nodules, number, nature of nodule, 
vascularity of nodules. Nodule less than 0.3 cm is identifiable in 
US. 
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 X-ray neck shows  ring or rim calcification; also reveals the 
position (displacement) and compression of trachea. 
 Indirect laryngoscopy to see vocal cords prior to surgery. occult  
recurrent laryngeal nerve (RLN) palsy. 
 Radioisotope iodine scan – in selected patients when indicated 
only. 
 Routine blood investigations, serum calcium. 
 CT Scan/MRI are routinely not indicated. It is done in retrosternal 
extension. 
TREATMENT 
Usually surgery is preferred.Reason for doing surgery in nodular goitre is -it is 
an irreversible stage and chances of complications like development of toxicity, 
haemorrhage and follicular carcinoma is high and also for cosmetic reason. 
 when entire gland is diseased, total thyroidectomy is a better option. 
 Subtotal thyroidectomy is done depending on the amount of gland 
involved, amount of normal gland existing and location of nodules-
commonly done procedure in multinodular goitre.Eight grams of thyroid 
tissue is retained in each lateral lobe. 
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 Often partial thyroidectomy or Hartley Dunhill operation is also done 
depending on the amount of diseased gland and normal tissues 
behind.Partial thyroidectomy is not well approved now. 
 Postoperative L thyroxine is often given to prevent any fluctuation is 
TSH level which may cause recurrent nodule formation. 
 Prevention of multinodular goitre is possible by supplementing with L-
thyroxine when patient develops goitre in puberty.Formation of nodular 
goitre can be prevented by correcting iodine deficiency by using iodine 
rich diet like eggs/seafood/milk or iodized salts and also avoiding 
goitrogenic drugs and diet. 
 Suppressive dose of L-thyroxine alone may be used occasionally in small 
nodule with limited results. TSH level shoud be supperessed 
consistentlybelow 0.5 ml IU/L.Problems are need of periodic monitoring 
with TSH estimation ; hormone insensitive part of thyroid tissue continue 
to grow;indefinite period of treatment;high recurrence after stopping L-
thyroxine.So it is not ideally accepted therapy. It is found that TSH 
suppression is of no use in treating residual/recurrent MNG. 
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DISCRETE THYROID NODULE 
 Discrete thyroid nodule is a clearly palpable nodule if clinically 
only a nodule is felt without palpable remaining gland OR it can 
be dominant nodule if clinically a nodule is felt in a palpable 
remaining gland OR it can be dominant nodule (30%)if clinically 
nodule is felt ina palpable remaining one or both lateral thyroid 
lobes. 
 A discrete thyroid nodule is common in females. Discrete nodule 
may be solid or cystic.USG,CT,MRI may confirm the diagnosis. 
 15% solitary/isolated nodule may be malignant;40% may be 
follicular adenoma.Other causes are thyroid cyst,thyroiditis or 
colloid degeneration. 
 
SOLITARY THYROID NODULE 
It is a single palpable nodule in thyroid  on clinical examination,in otherwise 
normal gland.Rest of the gland is impalpable. 
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CAUSES: 
1. Thyroid adenomas-20% 
 
a. Follicular – colloid(commonest);embryonal;fetal. 
 b.Hurthle cell. 
      Note:   papillary adenoma earlier called,was actually papillary carcinoma. 
2. Papillary carcinoma of thyroid-20% 
3. Only one nodule may be clinically palpable in an underlying multinodular 
goiter-50%. 
4. Throid cyst-10% 
TYPES 
1. Toxic solitary nodule -3-5% of solitary nodules of thyroid  
2. Nontoxic solitary nodule. 
         Based on radioisotope study: 
 Hot: Means autonomous toxic nodule. Normal surrounding 
thyroid tissue is inactive and so will not take up isotope. Nodule is 
overactive. It is 5% common of which only 5% can be malignant. 
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 Warm: Normally functioning nodule. Nodule and surrounding 
normal thyroid will take up isotope (active).It is 10% common of 
which 10% can be malignant. 
 Cold:Nonfunctioning nodule;may be malignant(need not be 
always).Nodule will not take up isotope (underactive).It is 80% 
common of which 20% are malignant. 
FEATURES 
 Single nodule palpable in one or  other lobes of the thyroid which 
is usually smooth and firm. 
 Lahey’s test does not show any other nodules in posterior part of 
the gland. 
 Hot or warm in 99m Tc scan but cold in I123 scan(discordant 
nodule)commonly they are malignant. 
 Thyroid nodule in children and elderly can be malignant. 
 Rapid enlargement of thyroid nodule can be malignant. 
 Tracheal deviation towards opposite side is common confirmed by 
trail sign,three –finger test,auscultation and X-ray neck. 
 30% of solitary nodules are cystic. 
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 20% of cold nodules are malignant. Cold nodule may be due to 
malignancy,thyroiditis,thyroid cyst or haemorrhage, benign 
adenoma. 
 Commonest site of a nodule is at the junction of isthmus with one 
of the lateral lobes. 
 Solitary thyroid nodule is the most common thyroid surgical 
disease. 
INVESTIGATIONS 
 U/S neck (very useful). 
 FNAC. 
 T3,T4,TSH. 
 Power Doppler is done to know the vascularity of the 
gland.Vascularity is described in resistive index(R1).Normal RI is 
0.65-0.7;if RI is more than 0.7 it indicates malignancy in that 
nodule.Malignant nodule shows anarchical angiogenesis.Flow 
pattern are:Type0- no flow; Type1:only peripheral flow; Type2: 
peripheral with small central flow; Type3:peripheral with 
extensive central flow;Type 4:only central flow. 
 Radioisotope study(I123/I  131/ 99mTc) 
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 Serum calcitonin estimation if FNAC confirms medullary 
carcinoma. 
 CT scan or MRI neck is not done routinely, but only in selected 
cases.Large swelling/to see vascularity/retrosternal extension are 
the indications. 
 X-ray neck to see tracheal deviation. 
TREATMEANT 
   Indicationsforsurgeryin solitary nodule thyroid 
Malignant nodule 
Follicular neoplasm 
Toxic nodule in young 
Nodule with obstruction 
Recurrent cystic nodule 
Complex cyst   
Cosmetic reason 
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 If it is a nontoxic nodule due to any cause,hemithyroidectomy 
with complete removal of lateral lobe and whole of the isthmus is 
done. 
 If it is papillary carcinoma thyroid,then near total thyroidectomy is 
done along with suppressive dose of L-thyroxine given 0.3 mg OD 
daily. 
 If it is a toxic nodule,radioiodine therapy,I131-5 milli curie is 
given orally ,if the age of the patient is more than 45 years. 
 If age is less than 45 years,then  initially  toxicity has to be 
controlled by antithyroid drugs,always followed by surgery-
Hemithyroidectomy. 
 If FNAC report says follicular adenoma,then hemithyroidectomy 
is done.If histology report says follicular carcinoma then 
completion total thyroidectomy is done.Completion 
thyroidectomy is done usually within 7 days or after 3 weeks.If 
frozen section biopsy proves carcinoma then total thyroidectomy  
is done. 
 If there is a nodule in the isthumus ,isthumectomy is done with 
excision of part of adjacent lateral lobes. 
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 If FNAC report says medullary carcinoma of thyroid,then total 
thyroidectomy with bilateral neck nodal dissection including 
central compartment is done. 
 Colloid nodule may respond for conservative drug treatment using 
thyroxine orally in 50% cases.If nodules reappears/enlarges 
progressively and significantly/causing cosmetic problem then 
hemithyroidectomy is indicated in  colloid nodule. 
RETROSTERNAL GOITRE 
             Retrosternal goitre is defined as having> 50% goitre below the 
suprasternal notch. 
 Primary is rare-1%.Primary retrosternal goitre arises from ectopic 
thyroid tissue from mediastinum.it gets its blood supply from 
mediastinum  itself,not from the neck.And also it is not related to 
the existing thyroid in the neck. 
 Secondary is common. It is extension from the enlarged thyroid 
from the neck.Usually arises from the lower pole of a nodular 
goitre.Commonly seen in short neck or obese individuals.Due to 
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negative intrathoracic pressure ,nodule gets drawn into the 
superior mediastinum. 
CLINICAL FEATURES 
 Dyspnoea at night during lying down or neck extended. 
 Cough and stridor . 
 Dysphagia. 
 Engorgement of neck veins and superficial veins on  the chest 
wall. 
 Lower border is not seen on inspection and not felt on palpation. 
 Pemberton’s sign is positive.The patient is asked to raise the arm 
above the shoulder level.Dilated veins are seen over neck and 
upper part of chest wall.Stridor and rarely dysphagia may 
occur.(when patient raises the arm above the shoulder level, 
retrosternal goiter  compresses over the easilycompressible 
structure like SVC and trachea causing dilated venis and 
dyspnoea  respectively). 
 Dull note over and  the sternum on percussion. 
 Retrostrernal goitre can be either nodular, toxic or malignant. 
 Rarely recurrent nerve palsy can occur. 
32 
 
 
DIFFERENTIAL DIAGNOSIS 
 Mediastinal tumours. 
INVESTIGATIONS 
 Chest X-ray shows tissue shadow under the sternum. 
 Radioactive iodine study is diagnostic. 
 CT scan is useful. 
 
TREATMENT 
 Surgical removal of retrosternal thyroid  is done. Commonly it 
can be removed through an incision in neck but in case of large 
retrosternal extension or in malignant type median sternotomy 
is required (rarely). 
THYROID NEOPLASMS 
 A.Benign 
a. Follicular adenoma-colloid,embryonal,fetal. 
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b. Hurthle cell adenoma. 
   Colloid adenoma(commonest adenoma) 
Papillary adenoma-its existence is doubtful.It is invariably low -grade   
    papillary carcinoma. 
B.Malignant(Dunhillclassification) 
a.Differentiated-80% 
1. Papillary carcinoma(60%). 
2. Follicular carcinoma(17%). 
 3.Papillofollicular carcinoma behaves like papillary carcinoma of 
thyroid. 
 4.Hurthle cell carcinoma behaves like follicular carcinoma. 
b.Undifferentiated-20%. 
        Anaplastic carcinoma(13%). 
c.Medullary carcinoma(6%). 
d.Malignant lymphoma(4%). 
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e.Secondaries in thyroid(rare) -from colon,kidney,melanoma,breast. 
Annual incidence of thyroid cancers is 3.7 per 1,00,000 population. It is 
common in females(3:1). 
Papillary carcinoma mainly spreads through lymphatics; follicular 
through blood; anaplastic through lymphatics and blood. 
Aetiology of Thyroid Malignancy 
1. Radiation either external or radioiodine can cause papillary 
carcinoma thyroid.There is increased incidence of thyroid 
carcinoma among children following exposure to ionising radiation 
after thenuclear disaster in Ukraine in 1986.Earlier irradiation was 
practised to head and neck region to treat benign conditions like 
tonsillitis,adenoids,thymus enlargement,acne 
vulgaris,haemangiomas during first two decades of life. As a 
consequence papillary carcinoma of thyroid. 
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DIFFERENTIATED THYROID CARCINOMA(DTC) 
DTC is a spectrum of disease derived from follicular cells.Both papillary 
and follicular carcinomas are grouped under this 90% of thyroid malignancies 
are differentiated .Papillary,follicular and Hurthle cell carcinomas are DTCs. 
AGES;AMES(LaheyClinic);MACIS; Sloan kettering scoring 
includeslow,intermediate and high risk groups.First three scoring systems have 
low and high risk groups.  
Papillary carcinoma spreads to lympth nodes;follicular carcinoma through 
blood.FCT causes pulsatile vascular secondaries. 
Incidence of thyrotoxicosis in DTCs is 2%. 
Galectin-3,RET/PTC rearrangements,CD44  
THYROIDECTOMY 
1) Hemithyroidectomy: Along with removal of one lobe, entire isthumus is 
removed. It is done in begin diseases of only one lobe. It is also done in 
follicular neoplasm involving only one lobe. Solitary toxic or nontoxic  
nodule, thyroid cyst are other indications. 
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2) Subtotal Thyroidectomy: Commonly  done in toxic thyroid either primary 
or secondary and  also often for nontoxic multinodular goitre. Here about 
8 grams, or a tissue, size of pulp of finger is retained on lower pole, on 
both sides and rest of the thyroid gland is removed. It is also done in 
MNG.  
3) Partial thyroidectomy (By Thomas)  is removed of the gland in front of 
trachea after mobilisation. It is done in nontoxic  multinodular goitre. Its 
role is controversial. 
4) Near total thyroidectomy: Here bothlobes except the lower pole ( One or 
both sides) which is very close to recurrent laryngealnerve and 
parathyroid is removed ( To retain blood supply to parathyroids) It is 
done in case of papillary carcinoma of thyroid. 
5) Total thyroidectomy : Entire gland is removed. It is done in case of 
follicular carcinoma of thyroid, medullary  carcinoma of thyroid. 
6) Hartley Dunhill Operation is removal of one entire lateral lobe with 
isthums and partial/subtotal removal of opposite lateral lobe. It is done in 
non-toxic multinodular goitre. 4 grams of tissue is left behind only on one 
side. 
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PREOPERATIVE PREPARATION 
 Blood grouping and cross matching. Keep the required blood 
ready. 
 Indirect laryngoscopy. Patient is asked to tell ‘E’ to check the 
abduction of vocal cord. 
 Serum calcium estimation. 
 T3,T4,TSH 
 Thyroid antibodies 
 ECG and cardiacfitness  especiallyin toxic goitre 
 Lugol’s iodine 10 days prior to surgery to make gland firm and less  
vascular. 
 
PROCEDURE 
Position: 
 Under general anaesthesia patient is put in supine position with neck 
hyperexetended by placing a sand bag under shoulder – with table tilt of 10 
degree head up to reduce venous congestion. 
 
38 
 
Incision:  
 Horizontal crease incision is done, two finger breadth above the sternal 
notch, from one sternomastoid to the other ( Kocher’s thyroid incision) 
(Posterior margin of sternomastoid). 
 Skin and platysma are incised (Subplatysmal plane) – upper flap raised 
up to thyroid cartilage, lower flap up to sternoclavicular joint. Deep fascia 
is opened vertically in the midline. 
 Hemithyroidectomy: Entire one lateral and entire isthumus are removed 
retaining entire opposite lateral lobe. It is done in solitary nodule/toxic or 
nontoxic adenoma in one lobe. 
 Subtotal thyroidectomy- it is done in toxic/nontoxic multinodular goitre. 
Most of the gland except lower pole on both sides is removed. 
 Strap muscles are retracted: in large goitre they are often divided in upper 
part to retain their nerve supply ansacervicalis. Often anterior jugular 
veinn need to be ligated using 3 zero vicry1. 
 Pretracheal fascia is opened vertically to expose thyroid gland. Short 
stout middle thyroid vein which  enters the IJV is ligated immediately  
using vicry1 or silk and divided. 
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 Superior Pedicle is dissected. artery and vein are individually ligated and 
divided. 
 In olden days mass ligation close to gland at superior pole was the 
practice. Chances of injuring external laryngeal nerve and AV fistula may 
happen is mass ligation. Dissection is done in an avascular plane between 
criothyroid and gland. 
 Parathyroids both superior and inferior and indentified. They are 6x4x2 
mm in size weighing 50 mg with yellowish brown/orange brown colour. 
Both glands are indentified  and dissected.  Superior parathyroid is above 
and behind the junction of RLN and inferior thyroid artery: inferior 
parathyroid is below and in front of this junction. 
 Recurrent laryngeal nerve should be identified with careful dissection 
through its entire course. Riddle’s triangle is between inferior thyroid 
artery ,trachea medially. From this area  nerve runs upwards to enter the 
larynx at greater cornua of thyroid cartilage. Many branches of nerve and 
variations are common, should not use monopolar cautery here: only 
bipolar cautery should be used. Posterior extension of lateral thyroid 
lobes close to Berry’s ligament is called as Zuckerkandl tubercle which is 
seen in 40% of cases. Nerve runs upwards in a fissure between  
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zuckerkandl tubercle and thyroid gland. Non recurrent laryngeal nerve  is 
occasionally seen in right side due to failure of developmentof 4th aortic 
arch: it directly arises from vagus enters the larynx at the level of inferior 
horn of thyroid cartilage. 
 Inferior thyroid artery which is a branch of thyrocervical trunk ascends 
upwards reaching gland at its lower pole after turning towards  midline 
behind the carotid artery. This retains the blood supply of parathyroids   
which is important. In olden days ligation of inferior thyroid artery was 
done  away from the gland often in continuation using absorbable suture 
material is now not in practice. 
 Mobilized gland is removed. Critical points of recurrent laryngeal nerve 
are-at the entry of interior thyroid artery and crossing the nerve at 
suspensory ligament of Berry, at lower pole of the gland. 
 
COMPLICATIONS of THYROIDECTOMY 
1) Haemorrhage: 
   May be due to slipping of ligatures either of superior thyroid artery or 
other  pedicles or small veins. It causes hypotension, breathlessness and 
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compression over the trachea may cause severe stridor, respiratory 
obstruction due to tension haematoma under strap muscles. Then patient 
is shifted to operation theatre and under general anaesthesia exploration is 
done and bleeders are ligated. Blood transfusion may be required.  
2) Respiratory obstruction: 
   It may be due haematoma or due to laryngeal oedema or due to 
tracheomalacia or bilateral RLN palsy. Often emergency tracheostomy 
may be required as a life saving procedure. 
3. Recurrent laryngeal nerve palsy: 
       It can be transient or permanent. Transient is common. They usually require  
steroid supplement and speech therapy. Permanent  paralysis is rare. It  presents 
with hoarseness of voice, aphonia, aspiration, ineffective  cough. Unilateral 
injury can be well compensated. It is advisable to do routine postoperative ILS 
on 5th postoperative day. Later ILS is done in 4 weeks and 12 weeks. 
4. Hypoparathyroidism: 
 Mostly it is temporary due to vascular spasm of parathyroid glands occurs in 
2nd-5th post operative day. Present with weakness, +ve Chvostek’s   sign, 
carpopedal spasm, convulsions. Serum calcium estimation is done and then 10 
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ml of 10% calcium gluconate is given IV 8th hourly. After 3-6 weeks, patient is 
admitted, drug is stopped and serum calcium level isrepeated. 
5. Thyrotoxic crisis 2% (Thyroid storm) 
     Occurs in a thyrotoxic  patient inadequately prepared for thyroidectomy and 
often a thyroid stress. Other causes are infection, trauma , pre eclampsia, 
diabetic ketosis, emergency surgery. 
Features: It can present after surgery, with circulatory collapse, with severe 
dehydration, , hypotension, hyperpyrexia, tachypnoea, hyperventilation, 
palpitation, restlessness, tremor, delirium,diarrhoea, vomiting and cardiac 
failure,later coma. 
6. Injury to external laryngeal nerve causes weakness of cricothyroid muscle 
leading to alteration in pitch of voice, voice fatigue, breathy voice, frequently  
throat clearing. ILS reveals short hyperaemic vocal cords, lower level affected 
of the posterior  commissure to the paralyzed one. 
7. Hypothyroidism Revealed clinically after 6 months. 
8. Wound infection, stitch granuloma formation. 
9. Keloid formation. 
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10. Recurrent thyrotoxicosis  is 5% common. It is due to retaining of more 
thyroid tissue during thyroidectomy for toxic thyroid. It is difficult to manage. It 
is treated with antithyroid drugs. It is difficult to manage. It is treated with 
antithyroid drugs, radioiodine therapy or re-excision  surgically which is 
technically demanding. 
 
RECURRENT LARYNGEAL NERVE PALSY 
Anatomy and Relations of Nerves with Thyroid Gland: 
 External laryngeal nerve is a branch of superior laryngeal nerve.  Vagus 
gives superior laryngeal nerve branch at inferior ganglion  of vagus which 
is at the level of greater cornua of  hyoid bone  which in turn divides  into 
internal laryngeal and external laryngeal nerves. External laryngeal nerve 
runs close to superior thyroid vessels to supply cricothyroid muscle which 
is tensor of vocal cord. It may get injured while ligating superior pedicle 
causing  defective pitch of the voice. So upper pedicle of thyroid  should 
be ligated close to gland. 
 Recurrent laryngeal nerve is a branch of vagus which hooks around 
ligamentum  arteriosm with  arch of aorta on the left and right subclavian 
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artery on the right side. Nerve may lie within the ligament of berry 
(25%). Non recurrent laryngeal nerve may be present in 1 in 1000 cases 
with  a horizontal course. RLN supplies all muscles of the larynx except 
cricothyroid and also gives  sensory supply of larynx below the vocal 
cords. 
MUSCLES OF THE LARYNX 
 Cricothyroid : It is the only muscle which is located on the external 
aspect of the larynx. It is supplied by external laryngeal nerve. 
 Abductors of the vocal cord – Posterior  cricoarytenoids. 
 Abductors of the vocal cord –Lateral  cricoarytenoids, transverse 
arytenoids, thyroaryteniods and cricoarytenoids. 
 Relaxant of vocal cords- thyroarytenoids and vocalis. 
 Muscles which close the laryngeal inlet – Oblique arytenoids and 
aryepiglottic. 
 Muscles which open the laryngeal inlet: Thyroepiglotticus. 
POSITION OF VOCAL CORD 
       Median, Paramedian (1.5 mm), normal cadaveric/neutral (3.5 mm), gentle 
abduction (7 mm), Completely abducted. 
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Assessment  of voice change:  
 Pitch of the voice – whether raised/lowered or pitch absent. 
 Breath support during speaking is adequate or not 
 Ability to alter the rapidity of speech – slow/fast/medium 
 Altered laryngeal and neck muscle tension. 
 Indirect laryngoscopy- with tongue pulled out using gauze, warmed ILS 
is placed  into the oral cavity to see vocal cords. patient is asked to say ‘e’ 
to see the vocal cord movements. 
TYPES 
1. Unilateral recurrent laryngeal nerve palsy. 
2. Bilateral recurrent laryngeal nerve palsy. 
3. Unilateral,combined recurrent laryngeal and superior laryngeal nerve  
    palsy. 
1.UNILATERAL RECURRENT LARYNGEAL NERVE PALSY 
All intrinsic muscles of the larynx except cricothyroid are 
paralyzed.Vocal cord becomes median or paramedian position. 
Reasons are; 
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a) Only retained cricothyroid is a weak adductor of vocal cord 
causing   median or paramedian position of vocal cords. 
b) Abductor fibres which are phylogenetically newer of the 
recurrent laryngeal nerve is moresusceptible and paralysed than 
adductor fibres. 
2.BILATERAL RECURRENT LARYNGEAL NERVE PALSY 
Both side intrinsic muscles are paralysed.So both vocal cords lie in 
median or paramedian position due to unopposed action of the both side 
cricothyroids. 
Clinical features 
 change in voice. 
 Severe dyspnoea and stridor leading to airway block and 
respiratory arrest. 
Treatment 
 Emergency tracheostomy. 
 Lateralisation of the cord by: 
• Arytenoidectomy by open surgery or through an endoscope. 
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• Vocal cord lateralisation through endoscope. 
 Excision of vocal cord through an endoscope or laser cordectomy. 
 Implantation of sternohyoid. 
 Thyroplasty. 
3. UNILATERAL, COMBINED RECURRENT LARYNGEAL NERVE 
AND   SUPERIOR LARYNGEAL NERVE PALSY  
All the muscles on one side are paralysed. Vocal cord is in cadaveric 
position,3.5 mm from the midline. 
Clinical features 
 Hoarseness of voice. 
 Aspiration through ineffective glottis. 
 Ineffective cough. 
Treatment 
 Speech therapy 
 Injection of Teflon to the paralysed cord. 
 Muscle or cartilage implant to the paralysed cord. 
 Arthrodesis of cricoarytenoid joint. 
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4.Bilateral,Combined Recurrent Laryngeal Nerve and Superior Laryngeal 
Nerve Palsy 
 All paralysis of intrinsic muscles of larynx  
 Total laryngeal anaesthesia 
 
Clinical features 
 Aphonia  
 Aspiration due to severe glottis incompetence and laryngeal 
anaesthesia. 
 Absence of cough. 
 Retention of secretions in the chest. 
 Respiratory arrest. 
Treatment 
 Emergency tracheostomy. 
 Fixing  epiglottis over the arytenoids to prevent aspiration. 
 Plication of vocal cords to prevent aspiration. 
 Total laryngectomy. 
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MATERIALS AND 
METHODS 
 
 
 
 
 In my study One hundred seventy seven patients with solitary thyroid 
nodule were analysed, sex distribution found to be 171 women &   6 men at our 
hospital. Age distribution found to  be   15 to 75 years (mean 42 years). Once 
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the presence of thyroid nodules were confirmed clinically, FNAC was done . 
these people were subjected to ultrasound neck along with Doppler imaging, 
We included only the nodules for which representative cytological material was 
available in FNAC. Ethical committee clearance was obtained and patients were 
enrolled for study after getting informed consent.  
 All  Doppler scans were performed with Siemens accuson , high-
frequency variable linear transducer , frequency used is 10  MHz (7.5MHz to 
10MHz). 
 Microscopic study of the FNAC specimens demonstrated that 119 of the 
177 nodules were benign, 29 had indeterminate cytology(follicular cells/ 
neoplasm) and 29 were malignant. 
      In 29 patients with follicular cytology, 27 were proceeded with surgery and 
post op biopsy revealed  19 patients with beningn disease and 8 patients with 
malignant disease. In this group of patients preoperative Doppler studies were 
correlated with post operative biopsy. In other patients Doppler studies were 
compared with FNAC   
B-Mode Ultrasonography 
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 USG neck has been a standard investigation in evaluation of thyroid 
nodules. It classifies thyroid nodules in to multi nodular goitre and solitary 
nodular goitre basedon number of  nodules. It also gives as an idea about the 
swelling that whether it is solid or cystic, also tells us the size , exact shape, idea 
about margins and adjacent tissue infiltration.  . 
 Echogenicity of the nodule has been compared with rest of the gland and 
categorised into hypo echoic , hyper echoic and nodules with mixed 
echogenicity. 
 Peripheral halo which is a significant indicator of benignity can be 
classified in to thick and thin based on thickness. If  less than 2mm , it is said to 
be thin halo and if more than 2mm , it is said to be thick halo.  
 Calcification can be seen through USG , parameters like thickness, 
posterior shadowing, posterior reverberation can be analysed. 
Microcalcification can indicate malignancy. 
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Power Doppler 
 Analysis of vascular patterns can be done by power Doppler, in our  study  
we customise the flow patterns in 5 groups 
 I- absent blood flow 
 II – flow pattern, exclusively perinodular  
 III-predominantperinodular blood flow (with some central flow) 
IV - predominant central flow (with insignificant perinodular flow) 
 V - only central blood flow. 
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Picture shows a colloid cyst with absent blood flow we categorise 
it as pattern I.
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exclusively perinodular blood flow seen in nodular goitre 
Categorised under pattern II 
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Predominant perinodular pattern of blood flow with less significant central 
blood flow seen in a case of  nodular goitre 
Categorised under pattern III 
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Perinodular blood flow is equal to intranodular blood flow 
In a patient with beningn follicular adenoma 
Categorised under group IV 
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Predominant central pattern in a patient with follicular carcinoma 
Categorised as pattern IV 
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Exclusive central blood flow 
Seen in a patient with follicular carcinoma 
Categorised as group V 
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Thick halo seen in a patient with chronic thyroiditis 
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Pulsed Doppler 
 Power Doppler analysis were qualitative and subjective, another method 
using spectral analysis is quantitative , objective and accurate. This can be done 
through pulsed Doppler by analysing 2mm thickness tissue. 
 The duplex indices obtained are resistance index [RI] and.Pulsatility 
index [PI]  
Formulas used for calculation: 
“PI=PSV-MDV/Mean Velocity” 
“ RI=PSV-MDV/PSV” 
(Where as PSV is peak systolic volume, MDV is mean diastolic volume) 
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Low resistance wave pattern seen on pulse Doppler ina patient with 
nodular goitre 
 
Typically seen in beningn lesions 
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High resistance blood flow pattern seen in a patient with follicular 
carcinoma 
Typically seen in malignant lesions 
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Ultrasound –guided Fine-needle Aspiration Cytology (FNAC)  
 After using the spectral analysis, FNAC was done. biopsy specimens 
were examined in conformity with the established criteria  by the “Papanicolaou 
Society of Cytology”. 
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OBSERVATION AND 
DISCUSSION 
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Statistical Analysis:  
 The association between the biopsy result and the qualitative variables 
(halo, echogenicity, margins, number of nodules, colour Doppler Study and 
calcification) and were assessed using likelihood  chi-square test. P value of < 
0.05 was considered significant. 
B-Mode USG: 
 Based on echogenicity sixty nine of the hundred and seventy seven 
nodules were hypoechoic, ten were hyperechoic, twenty were isoechoic, seventy 
two were mixed and six were anechoic. Statistical analysis didn’t reveal a 
significant statistical association between the cytological findings and the above 
parameters(P=0.059). Twenty nine of thirty seven malignant nodules were 
hypoechoic. Eighty seven of the hundred and seventy seven nodules showed 
peripheral halo. 
Three had suspicious cytology and only two had malignant cytology. Among 
the nodules without halo six were classified as suspicious, thirtyone were 
classified as malignant and thus the presence of halo was considered a 
significant evidence of benign lesion. Presence of a thick halo was a sign of 
malignant lesion and a thin halo was an important sign of benign lesion. 
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 Depth,width and Length measurements showed that malignant nodules 
were larger than indeterminate and benign nodules (P=0.001). Malignant 
nodules had an average width of 3.5 cm vs 1.75cm for benign nodules. 50 of the 
177 nodules showed calcifications. Among 50 nodules with calcifications, 10 
were coarse, fine in 37, mixed in 3. Twenty Seven of the 37 nodules with micro 
calcifications had malignant cytology. Thus the association between fine 
calcification and malignant were considered statistically to be significant (P= 
0.001). Micro calcifications were seen in twenty four of the thirtyseven 
malignant nodules. 
Power Doppler:  
 Vascularisation patterns were identified with Power Doppler USG on all 
177 nodules. It revealed that  
• thirteen nodules with pattern I (absent blood flow –these patients were 
not subjected to pulsed Doppler as there is no flow), 
• sixty-onehad  pattern II (exclusively  perinodularblood flow), 
• sixty-six had pattern III (perinodular blood flow equal or greater than 
central flow)  
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• twenty six had pattern IV (central blood flow greater than  perinodular 
flow) 
•  Eleven had Pattern V (exclusively central blood flow) 
In malignant nodules pattern IV and Pattern V were significantly 
associated with malignancy. Thirtyfive of thirtyseven malignant nodules 
showed these vascular patterns. 
Pulsed Doppler: 
 In malignant nodules mean PI is 1.54, (SD 0.033)and  mean RI is 0.75 
(SD 0.29).These values were statiscally significant and identify malignant 
nodules with good accuracy. 
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Descriptive Statistics 
 
 BENIGN MALIGNANT 
 n Min. Max. Mean S.D N Min. Max. Mean S.D 
Age 127 15 75 42.17 15.426 37 15 78 41.89 14.208 
RI 127 .532 .741 .61674 .043748 37 .699 
.812 .75319 .029478 
PI 127 .902 1.089 .96277 .031596 37 1.494 1.614 1.54873 .033278 
Stage 140 1 3 2.01 .802 37 3 5 4.16 .602 
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T-Test 
 n Mean S.D t df statistical inference  
Age       
BENIGN 127 42.17 15.426 .097 162 .923>0.05 
MALIGNANT 37 41.89 14.208   
Not Significant  
RI       
BENIGN 127 .61674 .043748 -17.811 162 .000<0.05 
MALIGNANT 37 .75319 .029478   Significant  
PI 
   
   
BENIGN 127 .96277 .031596 -98.084 162 .000<0.05 
MALIGNANT 37 1.54873 .033278   Significant  
Stage       
BENIGN 140 2.01 .802 -15.137 162 .000<0.05 
MALIGNANT 37 4.16 .602   Significant  
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Chi-square test 
 
Benign Malignant Total 
statistical inference 
n % n % N % 
Sex        
Male 3 9.2% 3 8.1% 6 3.7% X2=2.684 Df=1 
.101>0.05 
Not Significant 
Female 124 43.57% 34 91.9% 158 96.3% 
Stages        
I 13 9.2% 0 .0% 13 7.34% 
X2=143.14        
Df=4 
.000<0.05 
Significant 
II 61 43.57% 0 .0% 61 34.46% 
III 64 45.71% 2 5.4% 66 37.28% 
IV 2 0.11% 24 64.86% 26 14.68% 
V 
0 
 
.0% 11 29.72% 11 6.21% 
Total 140 100.0% 37 100% 177 100%  
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DISCUSSION 
 Due to the advent of technology innocent lesions are increasingly 
detected. As the resolution of thyroid ultrasound increases many nodules that 
are clinically not detected are being detected resulting in diagnostic and 
therapeutic confusions. Although B-mode USG is the investigation of choice for 
thyroid lesions but it cannot reliably differentiate benign lesions from malignant 
lesions. Preoperatively we largely rely on FNAC to find the nature of lesion. 
Though FNAC guides us through many clinical dilemmas, it has its own 
disadvantages.                   
 Increased vascularisation is well seen in tumour growth. It is now 
possible to identify vascular patterns inside superficial tissues with the invent of 
power Doppler. Thus this tool is very useful in studying and identifying thyroid 
nodules that should undergo FNAC. 
B-Mode USG Parameters: 
 Larger part of the nodules were hypoechoeic and mixed because we 
included those patients referred to our department after FNAC for screening 
sonography, if FNAC shows follicular cells (indeterminate) patients were asked 
to proceed with preop Doppler and post operative HPE report was correlated. 
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 In our study, of the thirty seven malignant nodules identified, eight  had mixed 
echogenicity and twenty nine had hypoechogenicity. 
 A significant evidence of benignity was the presence of halo. 
Anddo signified absence of malignancy.Another significant indicator of 
malignancy was decreased halo thickness. These results are in concordance with 
those in other studies. 
 USG can detect nodules in half of the population. Most of the detected 
nodules are less than 1.5 cm and are considered clinically occult nodules. 
FNAC has been advocated as the prime investigation for both occult and 
clinically palpable thyroid nodules, generally nodules less than 1.5 cm are 
followed up with clinical examination and ultrasound. 
Yet, sonographic features like microcalcifications, hypoechogenecity, irregular 
margins, can be exempted from follow up protocol and are managed more 
aggressively as they may indicate malignancy. 
 Fifty of the one seventy seven nodules had micro calcifications and 
twenty four of thirty seven malignant nodules had microcalcification. Our data 
are in accord with reports in the literatureand indicates that microcalcification is 
a good predictor of malignancy and are present in close to 65 percent of 
malignant nodules. 
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Power Doppler Indices: 
 Power Doppler helped to identify low velocity blood flow in vessels that 
previously could not be visualised .we adopted our own classification , based on 
vascular patterns by modifying the one proposed by “Lagalla et al”.  Our 
classification includes the followings 5 vascular patterns: 
• Absence of blood flow- Pattern I  
• Exclusively perinodular blood flow- Pattern II  
• perinodular  blood flow pattern is equal to central blood flow-pattern III  
• blood flow Central blood flow>perinodular  blood flow - patternIV  
• Exclusively central blood flow – pattern V. 
Nodules with vascular pattern III have a peripheral ring on USG colour 
Doppler. 
 Thirteen of the one seventy seven nodules in my study had no blood flow 
and no malignant nodule is listed in this group. These results are in around with 
number of published reports,where absence of blood flow signal is seen only in 
benign lesions.  
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   Though, both perinodular and central blood flow pattern is seen in both 
benign  and malignant nodules, central predominant flow is seen in malignant 
groups and perinodular predominant patterns  are seen in benign disease. 
 As the intranodular blood flow becomes more dominant the risk of 
malignancy increase. For Ex. (A small number of the nodules with pattern III 
blood flow (two of sixty six nodules) were malignant whereas (twenty four of 
twenty six nodules with pattern IV blood flow) and (all nodules with pattern V 
blood flow were malignant). “Holden identified carcinomas as having more 
concentrated intranodular blood flow” 
 “Cerbone et al7” made various studies and analysed, patterns of flow and 
increase in vascularity in malignant lesions and found that pattern of flow 
(central predominance) is more associated with malignancy, than increase in 
vascularity . 
 On comparing observed vascular patterns with our cytological findings 
we found that most benign nodules had vascular patterns II or III and accounted 
for 127. Though Pattern I and Pattern II were marked goes more in favour of 
benign nodules, pattern III is found in both benign and malignant diseases.  35 
of the 37 malignant nodules is associated with malignancy. 
 Doppler detection of nature of thyroid swelling depends on many 
technical aspects, like, wall pulse repetition frequency, filters signal 
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amplification,Doppler Sensitivity, intervening tissue attenuation and depth of 
region of interest. Even breathing and swallowing can create artefacts 
minimising the utility of application, in this study standard guidelines has been 
used to minimise these disadvantages. 
 Analysing the vascular patterns is rather subjective than objective, though 
guidelines has been followed in categorising patterns, still it is prone for 
error. This can be overcome by integrating the technology and software in 
to modern USG such that it objectively interprets patterns. 
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CONCLUSION 
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    USG evaluation of thyroid nodules by using power doppler caneffectively 
differentiate nodules with high risk  for malignancy from benign nodules . 
Power Doppler and RI have a high sensitivity and specificity in detecting 
malignancy. 
    Patients showing follicular cells in FNAC can reliably be differentiated in to 
benign and malignant groups using Doppler sonogram, which can bridge the 
limitation of FNAC which cannot identify malignant follicular neoplasm 
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MASTER CHART 
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S.NO NAME AGE/SEX BENIGN 
1 KAVITHA 40/F 0.573 0.967 III 
2 THAMARAISLVI 65/F 0.592 0.982 II 
3 DHAVAMANI 55/F 0.58 0.932 II 
4 LAKSHMI 22/F 0.592 0.933 II 
5 ANITHA 32/F 0.671 1.034 III 
6 PADMAVATHI 50/F 0.548 0.902 III 
7 KASTHURI 22/F 0.572 0.973 II 
8 MALARVIZHI 28/F 0.533 0.961 III 
9 BABY 50/F 0.592 0.922 II 
10 AMIRTHAM 57/F 0.627 0.932 III 
11 LATHA 30/F 0.624 0.944 II 
12 CHINNAPONNU 45/F 0.574 0.986 II 
13 ANUSHIYA 24/F 0.632 0.932 III 
14 DHANALAKSHMI 65/F 0.587 0.974 II 
15 SENBHAGAVALI 48/F 0.612 0.912 II 
16 VALARMATHI 19/F 0.684 0.982 II 
17 MANIYAMMAL 55/F 0.624 0.974 III 
18 ANJALI 60/F 0.592 0.941 II 
19 POONGODI 42/F 0.641 0.954 III 
20 PRIYADHARSHINI 28/F 0.654 0.944 III 
21 SAMBOORNAM 70/F 0.632 0.987 II 
22 CHINNAMMAL 65/F 0.613 0.971 III 
23 JEEVITHA 25/F 0.594 0.933 III 
24 GANAGAMSAM 55/F 0.575 0.924 III 
25 RAJAMANI 47/F 0.624 0.975 III 
26 VALLIAMMAI 65/F 0.633 0.994 III 
27 RASAMMAL 55/F 0.671 0.913 III 
28 MARIAMMAL 45/F 0.587 0.932 III 
29 RAJESWARI 38/F 0.594 1.001 II 
30 KAMU 50/F 0.632 1.054 III 
31 CHANDRA 50/F 0.644 1.041 II 
32 REETA 30/F 0.671 0.992 III 
33 RISABELLA 57/F 0.588 0.971 III 
34 PRIYA 26/F 0.647 0.988 II 
35 SUNITHA 34/F 0.672 0.947 III 
36 VENKATESWARI 15/F 0.678 0.978 II 
37 DHIVYA 18/F 0.634 0.972 III 
38 KASTHURI 22/F 0.546 0.974 III 
39 VAIJAYANTHI 24/F 0.574 0.946 III 
40 PAPPATHI 37/F 0.672 0.975 II 
41 GANESH 28/M 0.574 0.939 III 
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42 KALYANI 55/F 0.592 0.989 III 
43 GANGA 40/F 0.622 0.979 II 
44 DHANAM 60/F 0.642 0.994 III 
45 LAKSHMI 60/F 0.602 0.933 III 
46 GOVINDAMMAL 65/F 0.671 0.924 III 
47 ANSHARI 33/M 0.544 0.948 III 
48 KANISHKUMARI 30/F 0.542 0.974 II 
49 MALLIKA 55/F 0.556 0.937 III 
50 VIJAYAKUMARI 30/F 0.571 0.947 II 
51 VELAMMAL 50/F 0.672 0.982 II 
52 DHANALAKSHMI 55/F 0.613 0.914 II 
53 KOKILA 29/F 0.624 0.934 III 
54 KANAGA 28/F 0.633 0.978 III 
55 BAKKIYAM 58/F 0.534 0.933 III 
56 PACHAIYAMMAL 60/F 0.578 0.924 III 
57 SUBAIDHA 30/F 0.614 0.913 II 
58 THAMAYANTHI 32/F 0.672 0.972 III 
59 ELAKIYAM 60/F 0.682 0.971 II 
60 CHINNAMMAL 70/F 0.647 0.956 III 
61 RAJESWARI 40/M 0.637 0.942 III 
62 DHIVYA 23/F 0.574 0.944 II 
63 ALAGI 50/F 0.648 1.024 III 
64 PATTUROJA 40/F 0.624 0.971 III 
65 DEEPA 33/F 0.675 0.902 II 
66 AMUTHA 36/F 0.574 0.942 II 
67 GNANASUNDARI 53/F 0.533 0.922 III 
68 MALLIGA 53/F 0.594 1.003 II 
69 GANDHIMATHI 37/F 0.594 0.992 III 
70 SANGEETHA 22/F 0.674 0.974 II 
71 ELAKIYAM 33/F 0.584 0.972 III 
72 MARIAMMAL 45/F 0.584 0.992 III 
73 RAJESWARI 35/F 0.741 0.932 III 
74 KAMU 50/F 0.674 0.954 III 
75 CHANDRA 60/F 0.632 0.942 II 
76 VIJAYA 42/F 0.672 0.942 II 
77 KAMALA 45/F 0.594 1.089 III 
78 MARIAMMAL 24/F 0.574 0.934 II 
79 VASANTHA 56/F 0.586 0.942 III 
80 PARIPOORANAM 57/F 0.671 0.978 III 
81 JEEVAMANI 23/F 0.587 0.988 III 
82 NEELAVATHI 35/F 0.594 1.017 III 
83 NIRMALA 65/F 0.631 0.972 III 
84 LAKSHMI 65/F 0.574 0.958 II 
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85 DHANALAKSHMI 18/F 0.568 0.992 III 
86 NISANTHI 24/F 0.547 0.941 II 
87 ISWARYA 18/F 0.597 0.954 III 
88 MUTHULAKSHMI 36/F 0.632 0.975 III 
89 PARIMALA 27/F 0.644 1.003 II 
90 TAMILARASI 45/F 0.675 0.944 II 
91 SATHYA 33/F 0.654 0.999 II 
92 THESAIYAMMAL 55/F 0.641 0.932 III 
93 RAJKUMARI 70/F 0.592 0.947 II 
94 RAJESWARI 38/F 0.658 0.968 III 
95 PADMAVATHI 75/F 0.672 0.974 II 
96 MARIYAMMAL 60/F 0.588 0.931 II 
97 RENUGA 32/F 0.578 0.994 II 
98 SELVI 26/F 0.634 0.987 II 
99 VIJAYALASHMI 27/F 0.684 0.971 II 
100 LAKSHMI 60/F 0.642 0.986 III 
101 GOVINDAMMAL 65/F 0.654 0.994 II 
102 POONKODHAI 54/F 0.632 0.941 II 
103 AKILANDAM 45/F 0.592 0.988 II 
104 SUPATHRA 43/F 0.671 0.971 II 
105 DEEPA 31/F 0.642 0.932 III 
106 MARIYAMMAL 60/F 0.672 0.954 III 
107 KAMU       I 
108 AMARAVATHY       I 
109 MUTHULAKSHMI       I  
110 JAYALASHMI       I 
111 RAFIYABGAM       I 
112 PARVEN       I 
113 SHANTHI       I 
114 PRABHAWATHI       I 
115 AKILA       I 
116 KANNAMMAL       I 
117 THILAIYAMMAL       I 
118 JAYANTHI       I 
119 ASHOKKUMARI       I 
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INDETERMINATE CYTOLOGY IN FNAC. 
(Doppler findings correlated with post op HPE) 
1 AKASH 54/F 0.586 0.932 II 
2 SENTHIL 48/F 0.534 0.984 II 
3 SAROJA 34/F 0.654 0.971 III 
4 KAVITHA 31/F 0.674 1.009 III 
5 SUMATHI 32/F 0.671 0.992 II 
6 NEELA 21/F 0.577 0.994 III 
7 MANIVANNAN 27/F 0.568 0.942 II 
8 SUBASHINI 26/F 0.684 0.922 III 
9 PRAGALYA 16/F 0.634 0.971 III 
10 SEKAR 49/F 0.674 0.942 II 
11 MIRUNAZHILINI 60/F 0.612 0.972 II 
12 MIRUDULLA 21/F 0.622 0.986 II 
13 LEKHA 52/F 0.642 0.934 III 
14 SAHUNTHALA 31/F 0.594 0.974 III 
15 PRIYA 21/F 0.592 0.954 III 
16 MALLIKA 52/F 0.571 0.912 III 
17 THAILAMMAI 31/F 0.584 0.922 III 
18 SARANYA 21/F 0.532 0.974 II 
19 PUSPAM 39/F 0.554 0.934 III 
20 RUKUMANI 65/F 0.632 0.987 IV 
21 SAHUNTHALA 67/F 0.671 0.968 IV 
22 SANGEETHA 47/F 0.742 1.524 III 
23 DEVAGI 45/F 0.771 1.584 IV 
24 AMUTHA 39/F 0.724 1.582 IV 
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25 KUMARAN 45/F 0.711 1.554 IV 
26 LALITHA 48/F 0.714 1.574 IV 
27 NAGAVALLI 38/F 0.724 1.568           III 
28 DHIVYA 32/F 0.736 1.532 V 
29 MUTHU 51/M 0.742 1.584 IV 
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S.NO NAME AGE/SEX MALIGNANT 
1 JASMINE 35/F 
0.784 1.524 IV 
2 RASAMMAL 50/F 
0.724 1.571 V 
3 SUBASHINI 38/F 
0.764 1.614 IV 
4 SURYA 34/F 
0.774 1.582 IV 
5 PRAPAVATHI 34/F 
0.787 1.591 IV 
6 MURALI 35/M 
0.734 1.536 V 
7 FATHIMABANU 45/F 
0.747 1.524 IV 
8 LAKSHMI 52/F 
0.782 1.522 IV 
9 PONNAMBAL 61/F 
0.742 1.602 V 
10 EVANGELIN 25/F 
0.801 1.494 IV 
11 RAJAKUMARI 36/F 
0.812 1.527 IV 
12 BHARATH 29/M 
0.774 1.545 IV 
13 AMUSU 60/F 
0.742 1.514 III 
14 JAYASELI 35/F 
0.792 1.599 IV 
15 ALAGAMMAL 78/F 
0.812 1.524 IV 
16 SATHYA 24/F 
0.772 1.545 IV 
17 SUNITHA 20/F 
0.762 1.532 V 
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18 SUGANYA 15/F 
0.747 1.542 V 
19 PADMAVATHI 78/F 
0.722 1.547 IV 
20 KAVITHA 40/F 
0.747 1.609 IV 
21 THAMARAISELVI 65/F 
0.742 1.522 V 
22 DHAVAMANI 35/F 
0.732 1.496 IV 
23 LAKSHMI 47/F 
0.699 1.512 V 
24 ANITHA 32/F 
0.714 1.501 IV 
25 PADMAVATHI 50/F 
0.745 1.547 III 
26 KASTURI 42/F 
0.736 1.534 IV 
27 MALARVIZHI 28/F 
0.742 1.507 V 
28 PERIYANAYAGI 52/F 
0.782 1.574 V 
29 JENNIFER 30/F 
0.791 1.564 IV 
 
 
 
 
 
 
 
 
87 
 
 
 
 
 
 
 
REFERENCE 
 
 
 
 
 
 
88 
 
 
1) Solbiati L. Livraghi T, Ballarati E, et al. Ultrasound superficial structure: 
high frequencies, Doppler interventional procedure. New York, 
NY:Churchill Livingstone 1995. 
2) Tramallom J, Legger A, Correas JM. Et al. Imagerie du nodule thyroidien 
J Radiol 1999:80:271-7. 
3) Brander AE, Viikinkoski VP, Nickles JI, et al. Importance of thyroid 
abnormalities detected at US screening a 5-year follow up Radiology  
2000:215:801=6. 
4) Naik KS, Bury RF, Imaging the thyroid Clin Radiol 19988:53:630-9. 
5) Sabel MS, Haquw D, Velasco JM,  et al. Use of ultrasound –guided fine 
needle aspiration biopsy in the management of thyroid disease. Am Surg 
1998:64L:738-41. 
6) Lagalla R, Caruso G, Novara V, et al. Analisi flussimetrica nella patologia 
titoidea : ipotesi di integrazione con to studio qualitative con-color 
Doppler Radiol Med 1993:85:606-10. 
7) Cerbone G, Spies S, Colao A, et al. Power Doppler improves the 
diagnostic  accuracy of color Doppler ultrasonograohy in cold thyroid 
nodules : follow-up results. Hormone res 1999:52:19-24. 
 
 
89 
 
8) Ross DS, Evaluation of the thyroid nodule. I Nucl Med 1991:32:2181:92 
Holden A, The role of color  and duplex Doppler ultrasound in 
theassessment at thyroid nodules. Australian Radiol 1995:39:343-92. 
9) Solboati L, Cioffi V, Ballarati E, Ultrasonography of theneck Radiol Clin 
Noirth  Am 1992:30:941-54. 
10) Burns P, Interpreting and analyzing  th Doppler examination. In Taylor  
KJW Burns P, Wells PNT: Clinical applications of Doppler ultrasound  
2 nd New York NY: Raven Press 1995:PP 55-98. 
11) The Papanicolaou Socitey of Cytopathology Task Forces on Stanbdards  
of Practice for the examination of fine-needle aspiration specimens from  
thyroid nodules. Diagn Cytopathol 1996:15:84-9. 
12) Rsener B, Fundamentals of biostatistics 2nd Boston MA:PSW  publishers  
1986. 
13) Ahuja At, The thyroid and Prarathyroid In Ahuja A, Evans R Practical  
head and neck ultrasound LKondon: UK Greenwich Medical Media  
2000:PP 37-59. 
14) Gharib H, Thyroid Nodules: Management controversies Washigton Mayo  
Foundation 1995-1-111 (Ls) 
15) Dlum M,Yww J, Opperheimer JH, Advances in thyroid imaging thyroid  
sonography when and how should it be used? Thyroid Today1997:20:1-1 
90 
 
16) Takashima S, Fukuda H, Nomma N, Thyroid nodules re-evaluation with 
ultrasound: Clin ultrasound 1995:23:179:84 
17) Shimamoto K, Satake H, Sawaki Preoperative staging of thyroid papillay 
carcinoma with ulrtasonography Eur J, Radiol 1998:29:4-10 
18) Rago Vitti P, Chonovato L, Role of convential ultra sonography and color 
flow-Doppler sonograp[hy in predicting malignant in could thyroid 
nodules Eur J Endocronic 1998:138:41-6. 
19) Gritzmann N, Koischwitch D, Rettenbacher T, Sonography of the thyroid 
and parathyroid glands Radioal Clin North Am 2000:38:1131:45. 
 
 
 
 
 
 
 
 
 
91 
 
CASE   PROFORMA 
                                                       
Name:                                     Age/SEX:                   IP.NO:        UNIT:                                  
 
Date of admission:                                Date of Discharge: 
1. COMPLAINTS: 
a. Swelling in neck 
         i) Duration                                                 ii)Onset and progression:  
         iii) Associated complaints 
b.  H/S/O hyper or hypo thyroidism 
c. H/O hoarseness of voice, dyspnoea and dysphagia 
d. H/S/O metastasis 
e. H/O loss of weight, loss of appetite 
f. H/O trauma 
 g. H/O Fever 
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2. PAST HISTORY: 
         a) H/o Previous operation 
         b) H/o radiation to neck 
 c) Any comorbid illness                                                                                                                                                                      
HT/DM/TB/COPD/CAD. 
3. PERSONAL HISTORY: 
a) Diet : Mixed / Vegetation  
b) Appetite: Good / Impaired 
c) other adverse social practices 
 
4. FAMILY HISTORY: 
         Any other member of the family suffered from similar disease 
5. GENERAL PHYSICAL EXAMINATION: 
 a) Vital signs: 
Pulse:                                                                     Blood Pressure: 
 Temperature:                                                          Respiratory rate: 
b) Built and Nutrition: 
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c) State of hydration 
d) Anaemia / Jaundice / Pedal edema / Lymphadenopathy 
e) eye signs 
f) facies, tremors, palms and soles 
 
6. EXAMINATION OF THE NECK: 
a) Inspection 
1. Shape                                                              2.size 
3. Site                                                                 
4. Movement with deglutition/ protrusion of tongue 
5. Skin over swelling                                          6. Lower border visible 
7.  Trachea  :                                                   
 
b) Palpation: 
1. Shape                                           2. size 
3. site                            
4. movement with deglutition 
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5.lower border palpable 
6. surface of swelling 
7. carotid pulsation 
8. Trachea   
9. lymph nodes 
   c) Percussion 
mediastinal widening 
d) Auscultation 
          Bruit 
  
7. EXAMINATION OF OTHER 
SYSTEMS 
a. Cardiovascular system 
 b. Respiratory system 
c. abdomen 
d.Nervous system 
e. Spine and cranium 
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8. INVESTIGATION 
Blood investigations: 
1.Hb%                           TC                                               Blood Group 
2. RBS, Urea, Creatinine 
3. thyroid function tests 
4.Xray STNL 
5.USG neck  
6. USG Doppler thyroid 
7. FNAC of swelling 
8. Histopathological examination 
9. ECG/Cardiac evaluation 
10. Remarks 
 
 
 
